| (4-chloro-2-methylphenoxy)acetic acid | affects expression | ISO | RGD:3697 | 6480464 | 2-Methyl-4-chlorophenoxyacetic Acid affects the expression of SLC1A2 protein | CTD | PMID:16019039 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SLC1A2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC1A2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | ISO | RGD:732300 | 6480464 | Estradiol results in decreased expression of SLC1A2 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | ISO | RGD:732300 | 6480464 | Estradiol results in decreased expression of SLC1A2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 17beta-estradiol | multiple interactions | ISO | RGD:3697 | 6480464 | Pertussis Toxin inhibits the reaction [Estradiol results in increased expression of SLC1A2 protein] | CTD | PMID:22645130 |
| 17beta-estradiol | increases expression | ISO | RGD:3697 | 6480464 | Estradiol results in increased expression of SLC1A2 protein | CTD | PMID:22645130 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:732300 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:732300 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC1A2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732300 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC1A2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732300 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC1A2 mRNA | CTD | PMID:21998131 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:3697 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC1A2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3697 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC1A2 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC1A2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of SLC1A2 mRNA | CTD | PMID:15251184 |
| 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | ISO | RGD:732300 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of SLC1A2 mRNA | CTD | PMID:17547211 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SLC1A2 mRNA] | CTD | PMID:19467301 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of SLC1A2 mRNA | CTD | PMID:15251184 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of SLC1A2 mRNA | CTD | PMID:15251184 |
| aflatoxin B1 | increases expression | ISO | RGD:732300 | 6480464 | Aflatoxin B1 results in increased expression of SLC1A2 mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:732300 | 6480464 | Tretinoin results in decreased expression of SLC1A2 mRNA | CTD | PMID:21934132 |
| all-trans-retinol | multiple interactions | ISO | RGD:732300 | 6480464 | Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein] | CTD | PMID:17138558 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A results in increased expression of SLC1A2 protein | CTD | PMID:17138558 |
| all-trans-retinol | increases expression | ISO | RGD:732300 | 6480464 | Vitamin A results in increased expression of SLC1A2 protein | CTD | PMID:17138558 |
| ammonium chloride | affects expression | ISO | RGD:3697 | 6480464 | Ammonium Chloride affects the expression of SLC1A2 mRNA | CTD | PMID:16483693 |
| ampicillin | increases expression | ISO | RGD:732300 | 6480464 | Ampicillin results in increased expression of SLC1A2 protein | CTD | PMID:17138558 |
| Aroclor 1254 | decreases expression | ISO | RGD:3697 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC1A2 mRNA; more ... | CTD | PMID:22627295 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732300 | 6480464 | Benzo(a)pyrene results in decreased expression of SLC1A2 mRNA | CTD | PMID:22316170 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of SLC1A2 mRNA | CTD | PMID:15674843 |
| bleomycin A2 | increases expression | ISO | RGD:3697 | 6480464 | Bleomycin results in increased expression of SLC1A2 mRNA | CTD | PMID:15808516 |
| ceftriaxone | multiple interactions | ISO | RGD:3697 | 6480464 | Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein] | CTD | PMID:19717140 |
| ceftriaxone | increases expression | ISO | RGD:3697 | 6480464 | Ceftriaxone results in increased expression of SLC1A2 protein | CTD | PMID:19625514 |
| chlorpyrifos | decreases expression | ISO | RGD:3697 | 6480464 | Chlorpyrifos results in decreased expression of SLC1A2 mRNA | CTD | PMID:17452286 |
| chlorpyrifos | multiple interactions | EXP | | 6480464 | [Chlorpyrifos co-treated with NGF protein] results in increased expression of SLC1A2 mRNA | CTD | PMID:20600679 |
| cisplatin | decreases response to substance | ISO | RGD:732300 | 6480464 | SLC1A2 gene mutant form results in decreased susceptibility to Cisplatin | CTD | PMID:21471434 |
| clozapine | decreases activity | ISO | RGD:3697 | 6480464 | Clozapine results in decreased activity of SLC1A2 protein | CTD | PMID:11443521 |
| clozapine | decreases expression | ISO | RGD:3697 | 6480464 | Clozapine results in decreased expression of SLC1A2 mRNA | CTD | PMID:12873733 |
| clozapine | decreases expression | ISO | RGD:3697 | 6480464 | Clozapine results in decreased expression of SLC1A2 protein | CTD | PMID:11443521 |
| cobalt atom | multiple interactions | ISO | RGD:732300 | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of SLC1A2 mRNA | CTD | PMID:18078969 |
| cocaine | multiple interactions | ISO | RGD:3697 | 6480464 | Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; more ... | CTD | PMID:19717140 |
| cocaine | decreases expression | ISO | RGD:3697 | 6480464 | Cocaine results in decreased expression of SLC1A2 protein | CTD | PMID:19717140 |
| copper(2+) sulfate | decreases expression | ISO | RGD:732300 | 6480464 | Copper Sulfate results in decreased expression of SLC1A2 mRNA | CTD | PMID:19549813 |
| corticosterone | multiple interactions | ISO | RGD:732300 | 6480464 | Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein]; more ... | CTD | PMID:17138558 |
| corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of SLC1A2 protein | CTD | PMID:17138558 |
| corticosterone | increases expression | ISO | RGD:732300 | 6480464 | Corticosterone results in increased expression of SLC1A2 protein | CTD | PMID:17138558 |
| coumarin | increases expression | ISO | RGD:3697 | 6480464 | coumarin results in increased expression of SLC1A2 mRNA | CTD | PMID:18480146 |
| diarsenic trioxide | decreases expression | ISO | RGD:732300 | 6480464 | arsenic trioxide results in decreased expression of SLC1A2 mRNA | CTD | PMID:17547211 |
| diazinon | decreases expression | ISO | RGD:3697 | 6480464 | Diazinon results in decreased expression of SLC1A2 mRNA | CTD | PMID:17452286 |
| dioxygen | affects expression | ISO | RGD:3697 | 6480464 | Oxygen deficiency affects the expression of SLC1A2 protein | CTD | PMID:15927375 |
| ethanol | multiple interactions | ISO | RGD:3697 | 6480464 | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid inhibits the reaction [Ethanol results in decreased expression of SLC1A2 mRNA] | CTD | PMID:20655511 |
| ethanol | decreases expression | ISO | RGD:3697 | 6480464 | Ethanol results in decreased expression of SLC1A2 mRNA | CTD | PMID:20655511 |
| genistein | multiple interactions | ISO | RGD:3697 | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of SLC1A2 mRNA | CTD | PMID:21782745 |
| haloperidol | decreases expression | ISO | RGD:3697 | 6480464 | Haloperidol results in decreased expression of SLC1A2 mRNA | CTD | PMID:12873733 |
| hydrogen peroxide | multiple interactions | ISO | RGD:732300 | 6480464 | Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein] | CTD | PMID:17138558 |
| hydrogen peroxide | decreases expression | ISO | RGD:732300 | 6480464 | Hydrogen Peroxide results in decreased expression of SLC1A2 protein | CTD | PMID:17138558 |
| indole-3-methanol | affects expression | ISO | RGD:3697 | 6480464 | indole-3-carbinol affects the expression of SLC1A2 mRNA | CTD | PMID:21396975 |
| kainic acid | multiple interactions | EXP | | 6480464 | [Kainic Acid co-treated with zinc chloride] results in decreased expression of SLC1A2 protein | CTD | PMID:19061913 |
| ketamine | increases expression | ISO | RGD:3697 | 6480464 | Ketamine results in increased expression of SLC1A2 mRNA | CTD | PMID:20080153 |
| lead diacetate | decreases expression | ISO | RGD:3697 | 6480464 | lead acetate results in decreased expression of SLC1A2 mRNA | CTD | PMID:15985313 |
| lead(0) | decreases expression | ISO | RGD:3697 | 6480464 | Lead results in decreased expression of SLC1A2 mRNA; more ... | CTD | PMID:15955607 |
| LY294002 | multiple interactions | ISO | RGD:3697 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER protein] which results in increased expression of SLC1A2 protein] | CTD | PMID:22645130 |
| manganese atom | multiple interactions | ISO | RGD:3697 | 6480464 | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA]; more ... | CTD | PMID:22645130 |
| manganese atom | decreases expression | ISO | RGD:3697 | 6480464 | Manganese results in decreased expression of SLC1A2 mRNA; more ... | CTD | PMID:22645130 |
| manganese(0) | multiple interactions | ISO | RGD:3697 | 6480464 | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA]; more ... | CTD | PMID:22645130 |
| manganese(0) | decreases expression | ISO | RGD:3697 | 6480464 | Manganese results in decreased expression of SLC1A2 mRNA; more ... | CTD | PMID:22645130 |
| manganese(II) chloride | multiple interactions | ISO | RGD:3697 | 6480464 | Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA]; more ... | CTD | PMID:19615351 |
| manganese(II) chloride | decreases expression | ISO | RGD:3697 | 6480464 | manganese chloride results in decreased expression of SLC1A2 protein; more ... | CTD | PMID:19615351 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of SLC1A2 mRNA | CTD | PMID:17105907 |
| methamphetamine | increases expression | ISO | RGD:3697 | 6480464 | Methamphetamine results in increased expression of SLC1A2 mRNA | CTD | PMID:18419818 |
| methoxychlor | multiple interactions | ISO | RGD:3697 | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of SLC1A2 mRNA | CTD | PMID:21782745 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:3697 | 6480464 | Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein] | CTD | PMID:19717140 |
| ochratoxin A | affects expression | ISO | RGD:3697 | 6480464 | ochratoxin A affects the expression of SLC1A2 protein | CTD | PMID:20558201 |
| paclitaxel | decreases expression | ISO | RGD:3697 | 6480464 | Paclitaxel results in decreased expression of SLC1A2 protein | CTD | PMID:16361064 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC1A2 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SLC1A2 mRNA | CTD | PMID:18544908 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC1A2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of SLC1A2 mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of SLC1A2 mRNA | CTD | PMID:19482888 |
| pirinixic acid | increases expression | ISO | RGD:3697 | 6480464 | pirinixic acid results in increased expression of SLC1A2 mRNA | CTD | PMID:12832660 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of SLC1A2 mRNA | CTD | PMID:20813756 |
| quercetin | decreases expression | ISO | RGD:732300 | 6480464 | Quercetin results in decreased expression of SLC1A2 mRNA | CTD | PMID:21632981 |
| tetrachloromethane | decreases expression | ISO | RGD:3697 | 6480464 | Carbon Tetrachloride results in decreased expression of SLC1A2 protein | CTD | PMID:12629582 |
| toluene | affects expression | ISO | RGD:3697 | 6480464 | Toluene affects the expression of SLC1A2 mRNA | CTD | PMID:18653662 |
| trichostatin A | increases expression | ISO | RGD:732300 | 6480464 | trichostatin A results in increased expression of SLC1A2 mRNA | CTD | PMID:19924110 |
| valproic acid | multiple interactions | ISO | RGD:732300 | 6480464 | Valproic Acid promotes the reaction [HIST4H4 protein modified form binds to SLC1A2 promoter] | CTD | PMID:19924110 |
| valproic acid | multiple interactions | ISO | RGD:3697 | 6480464 | [Valproic Acid results in decreased methylation of SLC1A2 promoter] which results in increased expression of SLC1A2 mRNA | CTD | PMID:19924110 PMID:19924110 |
| valproic acid | increases expression | ISO | RGD:3697 | 6480464 | Valproic Acid results in increased expression of SLC1A2 mRNA | CTD | PMID:19924110 |
| valproic acid | multiple interactions | ISO | RGD:3697 | 6480464 | [Valproic Acid results in decreased methylation of SLC1A2 promoter] which results in increased expression of SLC1A2 mRNA | CTD | PMID:19924110 |
| valproic acid | decreases methylation | ISO | RGD:3697 | 6480464 | Valproic Acid results in decreased methylation of SLC1A2 promoter | CTD | PMID:19924110 |
| valproic acid | increases expression | ISO | RGD:732300 | 6480464 | Valproic Acid results in increased expression of SLC1A2 mRNA | CTD | PMID:19924110 |
| zinc atom | increases expression | ISO | RGD:3697 | 6480464 | Zinc deficiency results in increased expression of SLC1A2 protein | CTD | PMID:18755231 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | [Kainic Acid co-treated with zinc chloride] results in decreased expression of SLC1A2 protein | CTD | PMID:19061913 |
| zinc(0) | increases expression | ISO | RGD:3697 | 6480464 | Zinc deficiency results in increased expression of SLC1A2 protein | CTD | PMID:18755231 |